Navigation Links
TrialNetworks Customer to Present Results of Using Site Engagement Technology to Improve Study Operations and Patient Enrollment at Clinical Trial Optimization Conference

Needham, MA (PRWEB) September 27, 2013

TrialNetworks, an innovative technology company which provides the global pharmaceutical industry’s only Clinical Trial Optimization System, will sponsor and actively participate in the following prominent and collaborative events next month:

At Clinical Trial Optimization, a top-10 pharmaceutical company will present findings on using TrialNetworks technology to improve patient enrollment and trial execution in a global study. The TrialNetworks system is used by study sponsors from small biotechs to large global pharmas to optimize operations from startup through closeout – including feasibility, site activation, patient recruitment and retention, site engagement, trial conduct, online training, document management and more – all integrated within one centralized cloud-based platform.

Eric Silberstein, TrialNetworks CEO, said, “Our team is comprised of expert technologists with a deep understanding and appreciation of clinical research, and former study practitioners who are passionate about using technology to improve trial operations. We place tremendous value on sponsoring industry conferences because they provide an ideal opportunity to build strong relationships with key opinion leaders and learn about the evolving challenges our customers face.”

About TrialNetworks
TrialNetworks provides sponsors and CROs the industry's only Clinical Trial Optimization System. Using modern and intuitive technology, the TrialNetworks platform increases the quality and efficiency of clinical operations at each stage of a trial from feasibility through closeout. TrialNetworks apps, including Checklist, Document Library, Visit Guide, Action Items and Directory, are available in a unified and secure cloud-based interface. Customers ranging from Top 10 pharmaceutical companies to biotechs have implemented the TrialNetworks platform for use in Phase I-IV studies by more than 20,000 site staff in 60 countries. To learn why sponsors rely on TrialNetworks to optimize clinical trial operations, request a personalized demo at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Customer Satisfaction, A key to Success: Narang Medical Limited
2. TAKE Solutions Brings Together Leading Experts and TAKE Customers at “Converge 2012” to Discuss Business
3. Transportation and Energy Customers Look to Wharfedale’s SAP® Solutions with an Eye toward Cost Savings and Improved Operational Efficiencies
4. Sangui Bio Tech International Inc. - Over 500 Customers: Granulox Sales Ahead of Planning
5. Z Trim Holdings Grows Customer Base
6. BioInformatics LLC Announces New Market Report – Enhancing the Customer Experience: Insights and Life Science Supplier Rankings (13-002)
7. SoundConnect Announces New Not-For-Profit Customer in Smart Card Alliance
8. Rusterizer Gives Out Complimentary Rust Removers to First 100 Customers, My Cleaning Products Shares the Details
9. Puritan Medical Products Launches New Series to Tell Customer Stories
10. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
11. Centius – Partners with Engaged Nation– a Leading Gaming Industry Customer Loyalty Solution Provider to Help Maximize Customer Lifetime Value
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... ... were featured on AngelList early in their initial angel funding process. Now, they ... for individuals looking to make early stage investments in the microbiome space. ...
(Date:11/24/2015)... Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will be ... York on Wednesday, December 2 at 9:30 a.m. ET/6:30 ... CEO, will provide a corporate overview. th Annual ... 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola , ... corporate overview. --> th Annual Oppenheimer Healthcare Conference ...
(Date:11/24/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the ... the Toronto Stock Exchange, confirms that as of the ... developments that would cause the recent movements in the ... --> About Aeterna Zentaris Inc. ... Aeterna Zentaris is a specialty biopharmaceutical company engaged in ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The Academy of ... Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to represent the First–Person ... few years. Many AMA members have embraced this type of racing and several new ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... , Oct. 29, 2015  The J. Craig ... report titled, "DNA Synthesis and Biosecurity: Lessons Learned and ... Department of Health and Human Services guidance for synthetic ... 2010. --> --> ... also has the potential to pose unique biosecurity threats. ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):